Clinical-stage biopharmaceutical company developing therapeutic antibodies that target immuno-inflammatory regulators, leveraging biologic targets with human proof of mechanism
Clinical-stage biopharmaceutical company developing therapeutic antibodies that target immuno-inflammatory regulators, leveraging biologic targets with human proof of mechanism.